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Hox genes encode transcription factors that regulate the morphogenesis of developing embryos. In mammals, knowledge of the genetic
pathways, including the possible direct or indirect targets, regulated by HOX proteins is extremely limited. To identify the downstream genes
regulated by posterior HOX proteins, we expressed HOXA13 in mouse embryonic fibroblasts lacking paralog group 13 expression using a
bicistronic HOXA13/EGFP retroviral vector. Microarray analysis identified 68 genes with significant, reproducible RNA expression changes
(50 activated; 18 repressed) in stable HOXA13-expressing cells. Genes with the GO annotation terms bextracellular matrixQ and bbasement
membraneQ were greatly overrepresented, and several were shown to be regulated by HOX proteins in other studies. Among the genes
strongly activated by HOXA13 were Enpp2, a bifunctional enzyme known to modulate tumor and normal cell motility and which is
expressed in precartilaginous condensations; Fhl1, a transcription factor implicated in muscle cell differentiation and development; and
M32486, a putative integral membrane molecule expressed in the female reproductive tract. Expression differences in the HOXA13-
expressing cells were confirmed for selected downstream genes using semi-quantitative RT-PCR, and in vivo coexpression with Hoxa13 in
the limb interdigital mesenchyme was demonstrated for many. For two candidates, Igfbp4 and Fstl, interdigital limb bud expression was
reduced in Hoxa13 mutants. To explore whether paralogous and nonparalogous HOX proteins could regulate the same genes, we created new
HOX cell lines and examined the expression of selected genes identified by the HOXA13 screen. HOXD13 similarly activated/repressed 6
tested candidates, demonstrating that multiple downstream genetic pathways may be regulated by paralog HOX proteins. In contrast,
HOXA9 was only able to repress expression of some gene targets. A HOXD13 mutant, HOXD13IQN N AAA, incapable of monomeric DNA-
binding, activated the expression of 5 HOXA13-upregulated genes; but was incapable of repressing the expression of Ngef and Casp8ap2.
Our results suggest that HOX protein–protein interactions without direct HOX DNA-binding may play a larger role in HOX transcriptional
regulation than generally assumed, and DNA-binding appears critical for repression.
D 2004 Elsevier Inc. All rights reserved.
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(Krumlauf, 1994; McGinnis and Krumlauf, 1992). Each
protein contains a 60 amino acid DNA-binding domain
known as the homeodomain (HD) (Gehring et al., 1994a).
There are 39 mammalian Hox genes that are arranged in 4
linkage groups (A–D), each on a different chromosome.
Hox genes have been numbered 1–13 based on their
positions within each cluster; however, no single cluster
has the full complement of 13 genes due to gene loss. Genes279 (2005) 462–480
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as paralogs since their HDs are more similar to other paralog
members than those adjacent to them within the cluster
(McGinnis and Krumlauf, 1992; Ruddle et al., 1994). Loss-
of-function studies have demonstrated redundant functions
for paralogous as well as non-paralogous Hox genes (Favier
et al., 1996; Kondo et al., 1998; Zakany and Duboule,
1996). Whereas differences in paralog group function are
well delineated in the literature (Goff and Tabin, 1997; Zhao
and Potter, 2001, 2002), phenotypic variations in individual
Hox gene null phenotypes seem likely to be related to
quantitative differences between paralog gene expression
within individual cells (Greer et al., 2000; Wellik and
Capecchi, 2003). Despite the well-described redundant
functions, at least in terms of gross phenotype, individual
differences in paralogous protein sequence and tissue
expression suggests that at some level, unique functions
are likely to exist for individual members of a paralogous
group. Such qualitative characteristics acquired by divergent
duplicated genes are underemphasized.
All HOX HDs contain identical DNA-base contacting
residues consistent with their documented ability to bind
similar DNA sequences (Laughon, 1991), yet cofactors can
affect the affinity and specificity by which HOX proteins
bind DNA (LaRonde-LeBlanc and Wolberger, 2003; Mann
and Affolter, 1998). The similarity in DNA site recognition
and the minimal differences in affinity for sites between
individual proteins has created a conundrum of how
specificity is achieved, and two basic models have been
proposed to reconcile these observations: co-selective
binding and widespread binding (Biggin and McGinnis,
1997). In the first, cofactors, which bind DNA cooperatively
with the HOX protein, direct HOX proteins to specific
targets. In the second model, HOX proteins are bound at
many different sites in the genome, and cofactors may alter
the activity of HOX proteins in transcriptional regulation of
specific genes. Both models have support, although work in
Drosophila has demonstrated that homeodomain proteins
occupy a vast number of sites in vivo and are involved in the
regulation of greater than 25% of expressed genes (Liang
and Biggin, 1998; Walter et al., 1994).
If widespread binding also occurs in vertebrates, then
work to identify mammalian HOX-regulated targets would
enhance our understanding of the role of HOX protein
abundance in regulatory mechanisms as well as differences
between paralog groups in phenomena such as posterior
prevalence. Under the widespread binding model HOX
proteins would regulate a large set of common targets. Thus,
theoretically, virtually any cell type would be suitable to
identify HOX downstream genes and DNA-binding targets.
Despite the apparent simplicity of this argument, our
knowledge of HOX-regulated genes in mammals is very
limited (Boudreau and Varner, 2004; Bromleigh and Freed-
man, 2000; Bruhl et al., 2004; Chen and Ruley, 1998;
Dorsam et al., 2004; Edelman and Jones, 1995; Goomer et
al., 1994; Jones et al., 1992, 1993; Stadler et al., 2001;Valerius et al., 2002), and cis-acting sequences on which
these proteins exert their effects are few (Bruhl et al., 2004;
Chen and Ruley, 1998; Ferretti et al., 2000; Jacobs et al.,
1999). Moreover, the identification of targets in Hox mutant
animals is complicated by the fact that coexpressed
paralogous and non-paralogous HOX proteins provide
redundant functions. This paucity of known regulated genes
and authentic cis-acting sequences makes it difficult to
understand the details of HOX protein function. Such
aspects that need to be addressed include HOX protein
domain requirements, cofactors, necessity for direct HOX
DNA-binding, sites of interaction on chromatin, and the
extent of regulation by paralogous and non-paralogous
HOX proteins.
In this paper, we describe reproducible, endogenous gene
expression changes associated with the expression of a
HOX transcription factor. In this study, we do not differ-
entiate between direct or indirect downstream targets. We
exploited (1) an experimental context devoid of expression
from other paralog group 13 genes to study the effect of
HOXA13 at the transcriptional level using microarrays, and
(2) the dominance of posterior gene products in function
over anterior orthologs (Duboule and Morata, 1994; Goff
and Tabin, 1997; Zhao and Potter, 2001).Materials and methods
Retroviral vectors and cell lines
IRES-EGFP was subcloned from pIRES2-EGFP (Clon-
tech) into the pGEM5ZF plasmid (Promega), which had
been modified to contain an EcoRI site. Hoxa13 cDNAwas
subcloned from pCMV+ (Post et al., 2000) into the EcoRI
site 5V of the IRES-EGFP element. An AgeI/XhoI Hoxa13-
IRES-EGFP and IRES-EGFP-only fragment was then
cloned into the AgeI/XhoI sites of pRET2, a MoMLV-based
retroviral vector (Yang et al., 2002) at the respective sites.
Hoxd13, HOXD13IQN N AAA, and Hoxa9 cDNAs were
amplified by PCR and subcloned into the AgeI/EcoRI sites
5V of the IRES element.
All cell work was done using high glucose DMEM
media (GIBCO-BRL) supplemented with 10% FBS, 100
U/ml penicillin, 100 Ag/ml streptomycin, and 2 mM l-
glutamine (GIBCO-BRL). Phoenix-A amphotropic pack-
aging cells, from Gary Nolan (Stanford University, USA),
were transfected with retroviral vectors using the calcium
phosphate Pro-Fection kit (Promega). Retrovirus contain-
ing supernatants were collected at 24, 48, and 72 h post-
transfection from amphotropic cells, filtered through a .45
AM filter (Nalgene) and each collection was separately
incubated for 24 h with GP + E86 (derived from mouse
3T3 cells) ecotropic packaging cells (Markowitz et al.,
1990). After 72 h, homogeneous populations of infected
GP + E86 cells were isolated by GFP-based FACS. These
cell lines were than expanded and used for stable
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3T3 and C3H 10T1/2 cells were transinfected with filtered
supernatants from HOXA13/EGFP and EGFP-only eco-
tropic producer cells for 24 h. Enriched populations of
infected cells expressing the transgenes were collected
48 h post-infection.
Immunocytochemistry
NIH 3T3 cells were plated on cover slips 24 h prior to
transinfection with either HOXA13/EGFP or EGFP-only
viral supernatants. 48 h post-transinfection, HOXA13
expression was analyzed as previously described (Post et
al., 2000) with the following changes: fixation of cells was
done using 4% formaldehyde; rabbit anti-HOXA13 primary
antibody (Post et al., 2000) at a dilution of 1:200; goat anti-
rabbit rhodamine-conjugated secondary antibody (Santa
Cruz Biotechnology) at 1:500; cover slips mounted on
slides with VECTASHIELD mounting media containing
DAPI (Vector Labs). Photography was done using a Zeiss
Axioplan fluorescent microscope.
RNA isolation, cRNA synthesis, and gene expression
profiling
RNA was prepared from stable cell lines and trans-
infected cells. HOXA13/EGFP and EGFP-only GP + E86
stable viral producers (3 separate preparations), as well as
FACS enriched (EGFP-based) NIH 3T3 and 10T1/2 cells 48
h post-transinfection with ecotropic HOXA13/EGFP or
EGFP-only retroviruses (2 separate preparations) were
homogenized in the presence of Trizol reagent (Invitrogen)
and total cellular RNA was purified according to the
manufacturer’s procedures. This study utilized commer-
cially available high-density microarrays that produce gene
expression levels on 12,488 known mouse genes and
expressed sequence tags (Affymetrix; MG_U74Av2). The
preparation of cRNA, hybridization, and scanning of the
arrays were performed according to the manufacturer’s
protocols, as previously reported (Beer et al., 2002;
Schwartz et al., 2002). Probe intensities were extracted
from the images using Affymetrix software (Microarray
Suite 5.0).
Each probe set on the MG_U74Av2 arrays is composed
of numerous (~16) 25-base oligonucleotides complemen-
tary to a specific cRNA called perfect match (PM) probes,
and ~16 mismatch probes (MM) with sequences identical
to the PM’s except for alteration at the central base.
Publicly available software was used to process the probe
intensities (http://dot.ped.med.umich.edu:2000/pub/hox/
index.html), using a GFP-only transinfected 3T3 array as
the standard. Probe pairs for which PM  MM b 100 on
the standard were removed from the analysis. Then, for
each probe set on each array, PMMM differences were
trimmed by discarding the 25% highest and lowest differ-
ences, and the remaining differences averaged. The result-ing raw intensities for each array were normalized to the
standard using a piece-wise linear function that made 99
evenly spaced quantiles agree with the corresponding
quantiles in the distribution of the standard. Fold changes
were computed as the ratio of group means, after first
replacing means that were b100 by 100. Normalized
intensities were log-transformed in Excel spreadsheet
(Microsoft) by mapping x to log(max(x + 100,0) + 100).
Linear models (ANOVAs) were fit to the log-transformed
data that contained effects for the stable expressing and
transinfected cells, the treatment differences (HOXA13/
EGFP vs. EGFP-only), treatment by cell line interactions,
and effects for the replicate experiments for each cell line.
P values from resulting F statistics were calculated. The
inclusion of microarray data from the transinfected cells
aided the statistical comparison for the stable expressing
cells by improving the calculation of variance. Enriched
Gene Ontology terms were identified as previously
described (Creighton et al., 2003). More information is
available at the aforementioned web site.
Transient transfections and Western blotting
The stable expressing EGFP-only cells were transfected
with pCMV-cDNA expression vectors for Hoxa13 (Post and
Innis, 1999b) and Hoxd13. In brief, 24 h prior to trans-
fection, 400,000 cells were seeded in 6 cm dishes (4 per
condition). Transfections were performed using the Fugene
6 reagent (Roche) following the manufacturer’s protocol. 55
h post transfection, for each condition, RNA was prepared
from 3 dishes using the Trizol protocol (Invitrogen). The
fourth dish for each condition was used for protein
preparation. Cells were treated with trypsin, pelleted by
centrifugation and solubilized in 60 mM Tris, pH 6.8, 2%
SDS, 10 mM EDTA, 10 mM EGTA, and 10% glycerol.
Protein lysates were separated by electrophoresis using 12%
SDS-polyacrylamide gel, and proteins were subsequently
transferred to nitrocellulose. Western analysis used primary
antibodies at 1:10,000 for rabbit anti-HOXA13 (Post et al.,
2000), anti-HOXD13 (MAP-peptide with HOXD13 amino
acids 176–198), 1:1000 for anti-HOXA9 (Upstate Biotech-
nology), and 1:15,000 for donkey anti-rabbit HRP-conju-
gated secondary antibody (Amersham), each in PBST with
5% Carnation nonfat dry milk. Protein expression was
visualized using Supersignal chemilluminescent substrate
(Pierce).
RT-PCR
All RT-PCR experiments were performed using the One-
Step RT-PCR kit (Invitrogen) where the RT step was for 30
min at 508C; the PCR used an annealing temperature of
568C and an extension time of 45 s at 728C for 40 cycles.
Each primer pair was designed to amplify products spanning
multiple exons, thus distinguishing spliced mRNA from
genomic DNA amplification. Semi-quantitative RT-PCR,
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microarray experiments, was performed using serial dilu-
tions of total cellular RNA at final concentrations of 10,000,
2500, 625, 156, and 39 pg/Al. Control reactions were done
separately using 100 ng of murine genomic DNA or water
replacing the volume of input RNA. In vivo gene expression
was analyzed by RT-PCR using 300 ng of total RNA
isolated from mouse E12.5 forelimb autopods and 10-week-
old female cervix/vagina segments. The RT-PCR primer
pairs are: Anxa8 (CAGGATGGCCTGGTGGAAAGC) and
(CCTGGATCCACAAAGCCGCTC), Blnk (AGGCCCTC-
CAAGTGTTCCTCG and ACAGTCCCTGGAGGCGA-
CATG), Casp8ap2 (ACCATGGCAGCAGATGATGAC)
and (CCAAATGGGGAGATGTGGACTG), Col3a1
(CACAGTTCTAGAGGATGGCTG) and (GCCCTTCC-
AGATACTTGCAAG), Enpp2 (TGCTCAGAAGACTG-
CTTGTCC and CAGGCTGCTCGGAGTAGAAGG),
Fabp4 (CTGGAAGACAGCTCCTCCTCG and GCCTC-
TTCCTTTGGCTCATGC), Fbn1 (ATGAATGTCAGGC-
CATCCCAG and GGGTTCTTCTCACACTCATCC),
Fhl1 (ATAAGGTGGGCACCATGTCGG and GTGATT-
CCTCCAGATGTGATGG), Fstl (ACCTTCGCCTCTAA-
CTCGCTG and CACTGGAGTCCAGGTGAGAGTC),
Gas2 (ATGGATGCCAACAAGCCTGCC) and (TCCC-
AGCCTCCTCCCACTCG), Gjb3 (CCATGGACTGGAA-
GAAGCTC) and (TTCTCCGTGGGCCGAGCGATG),
Hoxa13 (TCGTGCGCGCAGCCTGCTTCG and GTCTG-
AAGGATGGGAGACGAC), Ifit1 (GTCAAGGCAGG-
TTTCTGAGGA and CGATAGGCTACGACTGCATAGC),
Ig fbp4 (CGGAAATCGAAGCCATCCAGG) and
(GCTGGCAGGTCTCACTCTTGG), Lamb3 (CC-
CACGCTGTGGAAGGGCAGG) and (CACAGTGGAGGQ
GCAGGAGGAG), M32486 (AGTAAGGTGTGCGCAAA-
CAGG and TCCCGACCGTGTGTGTGGTTG), Ngef
(TGTCCGGAAGATGAGCCGCAC and CTGGTCATG-
CAGCCGCTCACC), Ppic (CGAGGTCCCTCGGTG-
ACGGAC and CGATGGTGCAGTCGGTGAGTG) Tgtp
(CCACCAGATCAAGGTCACCAC and CTGTGCAAT-
GGCTTTGGCCAG). Reactions were resolved by agarose
gel electrophoresis with ethidium bromide and image
analysis was performed using the Quantity One software
with a Gel Doc 2000 (BioRad).
Whole mount in situ hybridization
For these experiments, the Hoxa13 deletion and replace-
ment with the neor mouse (Fromental-Ramain et al., 1996b)
was crossed onto the C57BL/6J genetic background for
seven generations to minimize variation in gene expression
arising from background differences. Embryos were col-
lected from matings of Hoxa13+/ mice at E11.5, E12.5,
and E13.5. Embryos were staged by assigning noon of the
day of vaginal plug, as E0.5. When needed, more precise
staging of limb buds was done as described previously
(Wanek et al., 1989). Genotyping for Hoxa13 was done by
PCR as previously reported (Post and Innis, 1999a) exceptfor adjustment of the MgCl2 concentration to 2.0 mM for
the null allele. Antisense mRNA probes were transcribed as
previously described for Hoxa13 and Hoxd13 (Post and
Innis, 1999a). In situ probe templates were created to the
bases from the following cDNAs cloned into pCR4
(Invitrogen): Anxa8 (809–1821), Col3a1 (3878–4704), Ifit1
(13–629), Igfbp4 (701–1128), and Sox9 (1475–2190).
EphB3 and Fstl templates were kindly provided by SA
Camper, and Image clones were purchased for Fhl1 and
Gas2 (Invitrogen Clone ID: 4988977 and 4237356). DNA
templates were linearized and antisense probes were tran-
scribed using the following restriction enzymes and RNA
polymerases: Anxa8 (NotI and T3), Col3a1 (NotI and T3),
EphB3 (NotI and T3), Fhl1 (KpnI and T7), Fstl (NotI and
T3), Gas2 (AvrII and T7), Ifit1 (NotI and T3), Igfbp4 (NotI
and T3), and Sox9 (NotI and T3). Whole-mount in situ
hybridization with a single digoxygenin-labeled RNA probe
was performed as previously described (Bober et al., 1994),
except that BM purple (Roche) was used as the substrate for
alkaline phosphatase.Results
Construction of cells stably or transiently expressing
HOXA13/EGFP and EGFP-only proteins
To avoid experimental complications caused by HOX
co-expression, we exploited a cellular context free of HOX
paralog group 13 activity in order to identify candidate
HOXA13 regulated genes. Ecotropic retroviral packaging
cells were created using the GP + E86 cell line, which was
derived from mouse NIH 3T3 embryonic fibroblast cells
(Markowitz et al., 1990), and which do not express
HOXA13 or HOXD13. HOXA13/EGFP and EGFP-only
viral packaging cells were created using MoMLV-based
retroviral vectors modified with a bicistronic Hoxa13-
IRES-EGFP expression cassette and control cells that
contain only the IRES-EGFP element (Fig. 1A). Retroviral
vector DNA was transfected into amphotropic Phoenix-A
cells to produce retroviral-containing supernatants. These
viral supernatants were then used to transinfect the GP +
E86 cells. The infected GP + E86 cells expressing the Hox
and/or GFP gene(s) were separated away from the
untransduced cells by GFP-based FACS (data not shown)
to create a heterogeneous population of ecotropic viral
producer cells, hereafter referred to as stable-expressing
cells. After this enrichment for cells expressing the
transgene(s), Western analysis demonstrated that only
the HOXA13/EGFP stable-expressing cells expressed
HOXA13 (Fig. 1B). In addition to stable expression of
these gene(s), these cells produce supernatants containing
competent ecotropic retrovirus that often have a high viral
titer and can be used for efficient infection in transient
infection/expression studies. Supernatants from these cells
were used to transinfect two murine embryonic fibroblast
Fig. 1. Creation of cells expressing either HOXA13/EGFP or EGFP-only. (A) Stable expressing retroviral producing cell lines were created using MoMLV-
based retroviral vectors modified with a bicistronic Hoxa13-IRES-EGFP expression cassette and only with the IRES-EGFP element. (B) Western blot
demonstrates HOXA13 expression in the HOXA13/EGFP but not the control EGFP-only retroviral producer cells. Equivalent amounts of protein were loaded
in each lane. (1) EGFP-only stable-expressing control cells; (2) EGFP-only transinfected 10T1/2 cells; (3, arrow) minimal expression of HOXA13 is detected in
the transinfected 10T1/2 cells; (4) HOXA13 expression in the stable-expressing cells; (5) expression of HOXA13 in the MLB13-myc cell line derived from
mouse limb buds. HOXA13 protein expression in our stable-expressing cell line is comparable to immortalized limb derived cells. (C) Immunocytochemistry
indicates expression of HOXA13 in transinfected NIH 3T3 cells using viral supernatants from HOXA13/EGFP but not the EGFP-only viral producer cells.
DAPI staining demonstrates that HOXA13 is localized to the nucleus. GFP expression shows successful transinfection by EGFP-only retrovirus. (D) GFP-
based FACS can enrich for near-pure cell populations expressing the transgene(s). HOX translation is initiated on a bicistronic message; EGFP expression, and
by inference HOXA13, is consistently ~3-fold lower in the HOXA13-expressing cells.
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E86 cells, do not express either HOXA13 or HOXD13 in
their untransduced state (data not shown). The goal of this
infection was to test downstream gene expression changes
48 h after expression of HOXA13. Immunocytochemistry
performed 48 h post-infection demonstrated expression and
nuclear localization of HOXA13 in the cells infected by
the HOXA13/EGFP virus, but not in those infected by the
control virus (Fig. 1C). In these experiments, the efficiency
of transinfection ranged from 10–80%, and GFP-based
FACS was used to enrich for a near homogenous
population of infected cells expressing the transgene(s)
(Fig. 1D). RNA (data not shown) and protein analysis
(Fig. 1B) showed significantly lower expression of
HOXA13 in the transinfected cells at 48 h post infection
compared to the stable-expressing cells. In addition,
HOXA13 protein expression in the HOXA13 stable-
expressing cell line was comparable to immortalized limb
derived cells (Rosen et al., 1994). Furthermore, we have
also observed similar levels of HOXA13 protein in
comparable amounts of limb bud protein preparations,suggesting that expression in our stable-expressing cells is
near physiological levels.
Gene expression changes unique to
HOXA13/EGFP-expressing cells
To identify candidate HOXA13 downstream genes,
transcriptional profiles were generated using murine
U74Av2 oligonucleotide arrays containing 12,488 probe
sets that interrogate expression levels of ~9000 distinct
genes. Total cellular RNA was prepared from two inde-
pendent samples of stable expressing HOXA13/EGFP and
EGFP-only cells, and two samples each from FACS-
enriched C3H 10T1/2 and NIH 3T3 cells 48 h following
transinfection with either HOXA13/EGFP or EGFP-only
retrovirus. These 12 RNA samples were analyzed using 12
separate arrays. Table 1 summarizes the number of probe
sets identified with reproducible, significant (P b 0.01)
expression changes for comparisons between HOXA13-
expressing and non-expressing control cells. Of the 12,488
probe sets on the microarray, the stable-expressing cells
Table 1
Reproducible expression differences between Hoxa13-expressing and non-
expressing cells
Cells P value b 0.01
(expected by chance)
P value b 0.01 and
fold change N 1.75
Stable-expressing
GP + E86 (3T3)
399 (125) 73
C3H 10T1/2 119 (125) 4
NIH 3T3 190 (125) 12
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differences (P b 0.01), with 399. For the transinfected cells,
119 and 190 probe sets showed significant differences for
the 10T1/2 and 3T3 cells, respectively. For each compar-
ison, assuming a false-positive rate of 1%, we would have
expected by chance to observe roughly 125 probe sets
meeting this significance level. To reduce the number of
false-positives, we added the co-requirement of a N1.75-fold
difference in mean expression levels for each probe set
between the HOXA13-expressing and non-expressing cells.
For the stable-expressing cell comparison, 73 probe sets
qualified, compared to 4 and 12 for 10T1/2 and 3T3 cells,
respectively. The only qualifying probe set in common
between the stable-expressing cells and either of the
transinfected cells was that for Hoxa13 in the 3T3 cells.
The relative paucity of probe sets with significant differ-
ences in expression for the transinfected cells, may be
explained by the lower level of HOXA13 expression in
these populations (Fig. 1B, compare lanes 3 and 4). The low
level of RNA expression for Hoxa13 in the transinfected
cells, as determined by the microarray, is consistent with the
low protein level. Despite this, the microarray data from
these transinfected cells was useful in estimating the
variance in gene expression between replicate stable-
expressing samples (see Material and methods).
We elected to focus our attention on the gene expression
changes in the stable-expressing cells. These gene expres-
sion changes were derived from two replicate experiments.
Permutation testing was performed in which (one or more)
pairs of samples were reversed in order to estimate the false-
positive rate (Tusher et al., 2001). Considering only those
permuted data sets where a pair of stable-expressing cells
were reversed, we obtained an average of only 12 probe sets
meeting the criteria of P b 0.01 and a fold change (FC) N
1.75 (either up or down) where we obtained 73 from the
actual data. Thus, permutation testing suggested that 12 of
73 could be false positives. Thus, ~84% of the changes are
more likely to have resulted from HOXA13 expression.
Of the 73 qualifying probe sets, 54 probe sets representing
50 different genes had higher expression in the HOXA13
stable-expressing cells (Table 2). Gene expression differ-
ences ranged between +30.75 for Fhl1 and +1.76 for Idb1.
Three probe sets for Aldh2 and a second probe set for both
Col3a1 and Fhl1 were in this group of upregulated probe
sets. Among these 50 genes are Anxa8 and M32486 genes
that have been identified in previous studies (Table 5) as
putative HOXA13-regulated targets (Zhao and Potter, 2001).19 probe sets, representing 18 different genes, were
identified as having significantly lower expression in the
HOXA13 stable-expressing cells (Table 3). The fold changes
within this group lie between 5.88 for Ngef and 1.75 for
Mox2. One of these 18 genes, Casp8ap2 was previously
shown to be upregulated by Hoxb4 (Morgan et al., 2004).
Functional categories of genes overrepresented in
HOXA13/EGFP-expressing cells
To determine the categories of genes regulated by
HOXA13, we tested whether any Gene Ontology (GO)
terms are overrepresented for the genes found as increased
in the HOXA13/EGFP-expressing cells compared to the
remaining genes assayed by the microarrays. Of the 399
probe sets with expression differences with a significance of
P b 0.01, we confined our analysis to those that met the
corequirement of having a FC N 1.0 (upregulated only) in
the HOXA13-expressing cells because this produced the
most biologically interesting data with the strongest
statistical support. This resulted in 208 qualifying probe
sets that were further reduced to 181 distinct genes for
which there are LocusLink identifiers and gene symbols
available. The remaining probe sets on the array correspond
to 8245 distinct genes with LocusLink identifiers. Using
publicly available software (Creighton et al., 2003) we
found 11 GO terms to be significantly enriched in this set of
upregulated genes (P b 0.001, Table 4). In order to assess
the chance that selection of these specific GO terms was a
false-positive result, we performed Monte Carlo simulations
in which 100 random sets of 181 gene symbols were chosen
from the arrays. Among these 100 data sets, we obtained an
average of only 0.8 GO terms with P b 0.001, and the
maximum number of terms in any single data set was 5.
Data for alternative analyses with different criteria for
expression differences is available at http://dot.ped.med.
umich.edu:2000/pub/hox/index.html. In general, these com-
parisons support the analysis above.
Validation of microarray identified expression differences
To validate the expression differences identified by the
microarray, we adapted a semi-quantitative RT-PCR (SQ
RT-PCR) method (Baigent and Lowry, 2000). RNA from a
preparation used for the microarray analysis and a third
independent preparation were used to verify the expression
differences for a subset of the 68 candidate HOXA13
regulated genes. Equal amounts of input RNA from both the
stable HOXA13-expressing (+) and non-expressing ()
cells were compared over serial dilutions ranging between
10,000 and 38 pg total RNA (Fig. 2). For each RNA
dilution, all other variables were held constant so that the
final signal was proportional to the amount of input RNA.
As a positive control, Hoxa13 expression was analyzed first
to demonstrate the ability of the assay to show differences in
expression between the RNA sources. Consistent with the
Table 2
Genes reproducibly upregulated at least 1.75-fold in stable Hoxa13-expressing cells
Gene symbol Mean fold change P value Description NCBI locus link
Membrane/cytoskeleton
Enpp2 10.81 0.0028 ectonucleotide pyrophosphatase/phosphodiesterase 2 18606
M32486 5.50 0.0000 Mouse 19.5 mRNA 56277
Gjb3 5.46 0.0058 gap junction membrane channel protein beta 3 14620
Itpr5 3.35 0.0005 inositol 1,4,5-triphosphate receptor 5 16442
Anxa8 3.26 0.0045 annexin A8 11752
Shrm 2.86 0.0027 shroom 27428
Blnk 2.81 0.0005 B-cell linker (lymphocyte antigen 57) 17060
Ly6c 2.49 0.0004 expressed sequence AA682074 17067
Syt8 2.48 0.0002 synaptotagmin 8 55925
Myo7a 2.20 0.0060 myosin VIIa 17921
Ly6a 2.17 0.0007 lymphocyte antigen 6 complex, locus A 110454
Synpo 2.02 0.0016 expressed sequence AW046661 104027
Extl3 1.93 0.0014 exostoses (multiple)-like 3 54616
Copz2 1.86 0.0095 coatomer protein complex, subunit zeta 2 56358
EphB3 1.85 0.0044 Eph receptor B3 13845
Ghr 1.82 0.0075 growth hormone receptor 14600
Ank3 1.78 0.0003 ankyrin 3, epithelial 11735
Metabolism/enzymes
Fabp4 3.76 0.0010 fatty acid binding protein 4, adipocyte 11770
Aldh2a 3.52 0.0007 aldehyde dehydrogenase 2, mitochondrial 11669
Aldh3a1 2.67 0.0012 aldehyde dehydrogenase family 3, subfamily A1 11670
Gstt1 2.58 0.0015 glutathione S-transferase, theta 1 14871
Lip1 2.16 0.0030 lysosomal acid lipase 1 16889
Ptgis 1.80 0.0034 prostaglandin I2 (prostacyclin) synthase 19223
P4ha2 1.80 0.0015 procollagen-proline, 2-oxoglutarate 4-dioxygenase 18452
Nuclear
Fhl1b 30.75 0.0005 four and a half LIM domains 1 14199
Hoxa13 20.70 0.0024 homeo box A13 15398
Ebf3 2.13 0.0064 early B-cell factor 3 13593
Tcf3 2.01 0.0052 transcription factor 3 21415
Idb1 1.76 0.0043 inhibitor of DNA binding 1 15901
Secreted/extracellular matrix
Fbn1 5.03 0.0000 fibrillin 1 14118
Fstl 4.61 0.0001 follistatin-like 14314
Igfbp4 2.91 0.0006 insulin-like growth factor binding protein 4 16010
Lamb3 2.83 0.0012 laminin, beta 3 16780
Col3a1b 2.77 0.0060 procollagen, type III, alpha 1 12825
Adm 2.75 0.0004 adrenomedullin 11535
S100a13 2.72 0.0004 S100 calcium binding protein A13 20196
Mfap5 2.55 0.0010 microfibrillar associated protein 5 50530
Col5a2 1.99 0.0006 procollagen, type V, alpha 2 12832
Col4a2 1.86 0.0048 procollagen, type IV, alpha 2 12827
Signal transduction/growth control
Tgtp 3.32 0.0003 T-cell specific GTPase 21822
Gas2 2.68 0.0027 growth arrest specific 2 14453
Adcy7 2.04 0.0040 adenylate cyclase 7 11513
Function not elucidated
Ifit1 4.37 0.0055 interferon-induced protein with tetratricopeptide repeats 1 15957
AA407270 2.58 0.0097 expressed sequence AA407270 270174
No Title 2.37 0.0022 ESTs 381697
BC028953 2.33 0.0013 DNA segment, Chr 14, ERATO Doi 231, expressed 210925
St5 2.10 0.0082 RIKEN cDNA 2010004M01 gene 76954
Aim1 1.98 0.0004 absent in melanoma 1 11630
1700020M16Rik 1.87 0.0061 RIKEN cDNA 1700020M16 gene 71843
No Title 1.81 0.0074 expressed sequence AI413214 66180
a Indicates that two additional probe sets identified the gene as being upregulated in the Hoxa13 expressing cells.
b Indicates that a second probe set identified the gene as being upregulated in the Hoxa13 expressing cells.
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Table 3
Genes reproducibly downregulated at least 1.75-fold in stable Hoxa13-expressing cells
Gene symbol Mean fold change P value Description NCBI locus link
Membrane/cytoskeleton
Klra4 1.92 0.0074 killer cell lectin-like receptor, subfamily A, member 4 16635
Mox2 1.75 0.0073 antigen identified by monoclonal antibody MRC OX-2 17470
Nuclear
Srrm1 2.44 0.0099 serine/arginine repetitive matrix 1 51796
Brul4 2.33 0.0052 Brunol4: bruno-like 4, RNA binding protein (Drosophila) 108013
Rag1 1.96 0.0071 recombination activating gene 1 19373
Secreted/extracellular matrix
Tpbpba 2.78 0.0012 trophoblast specific protein beta 116913
Ngfb 1.79 0.0043 nerve growth factor, beta 18049
Signal transduction/growth control
Ngef 5.88 0.0015 neuronal guanine nucleotide exchange factor 53972
Ramp3 2.38 0.0029 receptor (calcitonin) activity modifying protein 3 56089
Rgs2 2.17 0.0015 regulator of G-protein signaling 2 19735
Casp8ap2 1.89 0.0009 caspase 8 associated protein 2 (FLASH) 26885
Function not elucidated
4930553M18Rik 2.38 0.0093 RIKEN cDNA 4930553M18 gene 75316
No Title 2.17 0.0040 AK011460.1 –
1500034J01Rik 2.04 0.0002 RIKEN cDNA 1500034J01 gene 66498
5730408K05Rik 1.96 0.0077 RIKEN cDNA 5730408K05 gene 67531
Fin15 1.92 0.0053 fibroblast growth factor inducible 15 14210
2310005N03Rik 1.89 0.0026 RIKEN cDNA 2310005N03 gene 66359
4930553M18Rik 1.82 0.0012 RIKEN cDNA 4930553M18 gene 75316
a Indicates that a second probe set identified the gene as being downregulated in the Hoxa13 expressing cells.
Table 4
Significantly enriched ( P b 0.001) Gene Ontology (GO) terms assigned to upregulated genes
GO category GO term Count in 181
upregulated
genes with
P b 0.01
Count in
remaining
8051
genes
Fold
enrichment
of terma
P value,
one-sided
Fisher’s
Exact Test
Upregulated genes with this term
Cellular component extracellular matrix 13 134 4.4 0.000007 Col1a1, Col3a1, Col4a1, Col4a2,
Col5a2, Fbln2, Fbn1, Lamb2, Lamb3,
Mfap5, Mmp14, Smoc, Sparc
Molecular function extracellular matrix
structural constituent
7 36 8.9 0.000011 Col1a1, Col3a1, Col4a1, Col4a2,
Col5a2, Lamb2, Lamb3
Cellular component basement membrane 6 26 10.5 0.000017 Col4a1, Col4a2, Lamb2, Lamb3, Smoc1, Sparc
Cellular component clathrin vesicle coat 4 11 16.6 0.000066 Ap3s1, Ap3s2, Copz1, Copz2
Cellular component coated vesicle 6 41 6.7 0.000245 Ap3s1, Ap3s2, Copz1, Copz2, Sec23a, Syt8
Cellular component collagen 5 27 8.4 0.000263 Col1a1, Col3a1, Col4a1, Col4a2, Col5a2
Molecular function extracellular matrix,
structural constituent,
conferring tensile
strength
5 27 8.4 0.000263 Col1a1, Col3a1, Col4a1, Col4a2, Col5a2
Biological process protein transport 16 276 2.6 0.000359 Ap3s1, Ap3s2, Arfgap3, Bcap31, Copz1,
Copz2, Ctsb, Gabarap, Ghr, Lman1, Lrp10,
Rab25, Rin2, Sec22l1, Sec23a, Snap23a
Cellular component Golgi membrane 4 19 9.6 0.000673 Bcap31, Man2a1, Sec22l1, Sec23a
Biological process intracellular protein
transport
13 214 2.8 0.000837 Ap3s1, Ap3s2, Arfgap3, Bcap31, Copz1,
Copz2, Ctsb, Gabarap1, Lman1, Rab25,
Sec22l1, Sec23a, Snap23
Cellular component clathrin-coated
vessicle
5 35 6.5 0.000918 Ap3s1, Ap3s2, Copz1, Copz2, Syt8
Only distinct genes that had LocusLink indentifiers were used in statistical tests.
a Ratio of (Count in 181/181)/(Count in 8051/8245).
T.M. Williams et al. / Developmental Biology 279 (2005) 462–480 469
Fig. 2. Semi-quantitative RT-PCR validates expression differences for 10
candidate HOXA13 downstream genes. RNA from stable HOXA13/EGFP
(+) and EGFP-only () cells were compared across serial dilutions of input
RNA ranging from 10,000 to 39 pg/Al. Hoxa13 expression was tested as a
positive control and Ppic as a negative control of differential expression.
Consistent with microarray fold changes, of the 10 genes examined, 9 have
reproducibly higher expression in the HOXA13/EGFP cells, and 1 (Ngef)
has lower. Control reactions were included using water (W), RNA from
caudal female reproductive tracts (C/V), and genomic DNA (G).
T.M. Williams et al. / Developmental Biology 279 (2005) 462–480470microarray data, the assay reported no detectable difference
in the expression of Ppic, a housekeeping gene unlikely to
be regulated by HOXA13. Using this method, 11 of the
most highly differentially expressed 68 candidate down-
stream genes were tested. For 10 of the 11, the direction of
expression change was confirmed. Genes such as Fhl1,
M32486, and Enpp2, which were identified by the micro-
array to have large fold changes, were shown to have
dramatic changes in expression by SQ RT-PCR. In our
experience, this method repeatedly demonstrates accurate
directional changes in expression but can fail to detect
changes for targets with smaller fold changes, particularly
those with high basal expression in the cell line. For
example, Fstl was determined by the array to be expressed
4.61-fold higher in the HOXA13 stably expressing cells; by
SQ RT-PCR, at higher levels of input RNA, only a subtle
difference in expression was detected. As the input RNA
was reduced, the difference in expression became more
apparent. This may explain why the SQ RT-PCR failed to
detect a difference in the expression of Anxa8, a gene with a
smaller FC in expression (+3.26-fold) and is also highly
expressed in the EGFP-only cells (data not shown). To
further support the validity of these gene expressiondifferences, 7 of these 10 genes were tested by SQ RT-
PCR in a third independent preparation of RNA and shown
to have similar expression differences (data not shown).
Candidate downstream target gene expression in vivo
To determine whether some of these genes are normally
expressed in tissues that express HOXA13, and therefore
present an opportunity for regulation, we performed RT-PCR
on a subset of 16 candidates for expression in the developing
distal (autopod) limb bud (LB) and the caudal region of the
female reproductive tract consisting of the cervix and vagina
(C/V) (Fig. 3), two regions of known Hoxa13 expression
and function (Fromental-Ramain et al., 1996b; Taylor et al.,
1997; Warot et al., 1997). Expression was demonstrated for
each of the tested genes in at least one of the two RNA
sources, with Anxa8, Col3a1, Enpp2, Fbn1, Fhl1, Fstl,
Gas2, Ifit1, Ifgfbp4, and M32486 expressed highly in both.
Expression of Blnk, Fabp4, Gjb3, Lamb3, Ngef, and Tgtp
was faint in the LB compared to the C/V.
To determine whether any of the limb bud expressed
candidates have in vivo expression patterns that overlap
with Hoxa13, whole mount in situ hybridization was
performed using forelimbs and hindlimbs (Fig. 4). Between
early (stage 7) and mid (stage 8) E12.5 limb buds, Hoxa13
expression changes from being broadly expressed across the
entire anteroposterior axis of the distal autopod (Fig. 4B), to
being excluded from the prechondrogenic cartilage con-
densations of the developing digits while maintaining
expression within the interdigital mesenchyme (ID, Fig.
4C) (Suzuki and Kuroiwa, 2002). Expression in the ID can
be seen clearly for Anxa8, Fstl, and Igfbp4 (Figs. 4E,I,L).
The expression of Col3a1, EphB3, Fhl1, Gas2, and Ifit1
(Figs. 4F,G,H,J,K) also appear expressed in the ID, however
the signal was much lower, at least with the probes and
conditions used here. Previous studies have more clearly
demonstrated the IDM-restricted expression of EphB3 and
Gas2 (Compagni et al., 2003; Lee et al., 1999). Enpp2, also
known as autotaxin, has been shown to be expressed around
the developing digits in precartilaginous condensations and
joint regions beginning in the limbs at ~E14.5 (Bachner et
al., 1998, 1999). Our efforts to examine in situ expression of
this gene in limb buds at E12.5 were unsuccessful, despite
the positive signal by RT-PCR (Fig. 3). The distal joint
defects in Hoxa13 mutant mice and the fact that Enpp2 is
downstream in BMP2 metabolism makes Enpp2 a strong
candidate for HOXA13 regulation. Together, the expression
data from both RT-PCR and in situ hybridization demon-
strates coexpression for many candidate downstream genes
and Hoxa13 in the caudal female reproductive tract and/or
the developing limb buds of wild type mice.
Misregulation of Igfbp4 and Fstl in Hoxa13/ embryos
Using RNA from E12.5 Hoxa13+/+ and Hoxa13/
distal limb buds, no observable changes in expression were
Fig. 3. Expression analysis for 16 of the 68 candidate HOXA13 downstream target genes in tissues of known Hoxa13 expression. RT-PCR was performed
using RNA from developing distal limb buds (LB) and the caudal female reproductive tract (C/V). Control reactions that included water (W) instead of input
RNA were also performed for each gene.
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M32486 (data not shown), candidates with some of the
largest reported expression changes in the in vitro assayFig. 4. Interdigital limb bud expression of candidate HOXA13 target genes. Who
Schematic of an E12.5 limb bud indicating the position of anterior digit 1 (d1) and
the digital condensations are in purple, with interdigital regions specified (ID1–4
E12.5, Hoxa13 expression becomes restricted to the interdigital mesenchyme. (D)
not extend as far anterior (compare red arrows) as ID1 and d1. Coincident interdigi
(I) Fstl, (J) Gas2, (K) Ifit1, and (L) Igfbp4 at E12.5. Images (B, C, and G) are o(Table 2). This could be explained by the lack of strict
quantitative assay capabilities, pooling of the samples which
might have raised the contribution of cells normally notle mount in situ hybridization analysis for limb bud RNA expression. (A)
the progression to posterior-most digit 5 (d5). The mesenchyme surrounding
). (B) Hoxa13 expression at E11.5 is throughout the distal autopod. (C) At
Hoxd13 expression largely overlaps that of Hoxa13, but the expression does
tal expression is observed for (E) Anxa8, (F) Col3a1, (G) EphB3, (H) Fhl1,
f hindlimbs, and all others are forelimbs.
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have been optimal for seeing an expression difference, or
could result from the remaining expression of paralog
Hoxd13 and several nonparalogous Hox genes in the mutant
limb buds. This result would not preclude a change in the
distribution or relative abundance of candidate expression
that might be visualized in mutants using whole-mount in
situ hybridization.
To test whether Hoxa13 is required for ID limb
expression of selected candidate downstream regulated
genes, we compared expression in Hoxa13+/+ and
Hoxa13/ embryo limb buds by whole mount in situ
hybridization in several limb stages (Figs. 5 and 6). ForFig. 5. Misregulation of Igfbp4 expression in Hoxa13/ limb buds. Comparison o
embryos between E12.5 stages 7 and 9. (A) At stage 7, Igfbp4 is expressed primarily
and persisting through (C) stage 9. (D–F) While proximal expression is unaltered
pattern is seen in the (E) mutant limb buds compared to the ID2–4 expression in (B)
buds but not (C) wild type littermates (compare red arrows). Sox9 expression in fo
that mutant limb buds are at comparable developmental stages.Igfbp4, in both wild type and mutant embryos at early E12.5
(stage 7), there is high expression in the proximal forelimb
bud and to a lesser degree evenly throughout the distal
autopod (Figs. 5A,D). At mid E12.5 (stage 8), the proximal
expression of Igfbp4 remains in both wild type and mutant
forelimb buds, however ID expression turns on in the wild
type forelimb buds (Fig. 5B), while expression in the
mutants appears much weaker in several ID regions (Fig.
5E). By late E12.5 (stage 9), the expression of Igfbp4 in
wild type limb buds is strongest in ID1 and ID4, and weaker
in ID2 and ID3. In mutants at the same stage, Igfbp4 is
expressed in ID2–4 (albeit weaker in ID4), but not in ID1
(Fig. 5F).f Igfbp4 expression in forelimbs of (A–C) Hoxa13+/+ and (D–F) Hoxa13/
in the proximal limb bud, with interdigital expression apparent at (B) stage 8
in the mutant limb buds, at stage 8, a weaker and disorganized expression
wild type littermates. At stage 9, ID1 expression is absent in (F) mutant limb
relimbs of (G–I) Hoxa13/ and (J–L) Hoxa13+/+ littermates demonstrates
Fig. 6. Fstl expression is misregulated in Hoxa13/ embryos. (A) In late
E12.5 limb buds (stage 9, hindlimbs) of Hoxa13+/+ embryos, Fstl
expression is higher in ID2 and ID3. (B) At early E13.5 (stage 10,
forelimbs) limb buds, Fstl is highly expressed in the posterior ID4 relative
to ID1-3. In Hoxa13/ limb buds, Fstl expression is reduced at both (C)
stage 9 and (D) stage 10, most notably in the posterior ID4 at stage 10
(compare red arrows).
Fig. 7. Coregulation of candidate HOXA13 downstream genes by other
HOX proteins, and a variable requirement for monomeric DNA-binding
capability. Semi-quantitative RT-PCR comparison of gene expression in (A)
EGFP-only cells after transient expression of HOXA13 and HOXD13, and
(B) stable-expressing cells. (A) Transient expression of HOXD13, like
HOXA13, increases the expression of Blnk. (B) The expression of Enpp2,
Fabp4, and Fhl1 are increased in cell lines expressing HOXD13 or
monomeric DNA-binding mutant HOXD13IQN N AAA, but not in those
expressing HOXA9. Blnk and Ifit1 expression is increased only in
HOXD13IQN N AAA cells. Casp8ap2 and Ngef have reduced expression
in cells expressing either HOXD13 or HOXA9, but not in the cells
expressing HOXD13IQN N AAA. The amount of input RNA used for A, B,
and C was 10,000, 2500, and 625 pg/Al for Blnk, Casp8ap2, Enpp2,
Fabp4, Fhl1, Ppic, and 625, 156, and 39 pg/Al for Ifit1 and Ngef,
respectively.
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the proper staging of mutant and wild type limb buds to be
confident that the presented differences in expression are
due to the loss of Hoxa13 rather than a result of delayed
development or faulty staging. The misshapen appearance
of the Hoxa13 mutant limbs results from hypoplasia of the
developing digits and is not an indication of inappropriate
staging or absence of tissue in the mutant limbs (Fromental-
Ramain et al., 1996b). Sox9 expression at stages 8 and 9
reveals that the prechondrogenic condensations have sim-
ilarly developed in the Hoxa13/ embryos compared to
that seen in the wild type embryos (compare Figs. 5H,K).
This supports our conclusion that the stages presented are
indeed comparable and that subtle morphologic differences
result from hypoplasia of digits 1, 2, and 5 rather than a
developmental delay (Figs. 5G–L). Further examination of a
more advanced stage of Hoxa13/ limbs in Fig. 5F, by
comparison with Fig. 5B, shows clearly reduced levels of
Igfbp4 staining, and this is supported by the more advanced
Sox9 expression pattern for mutants shown in Fig. 5L.
These comparisons were repeated with five additional
mutant embryos, and a consistent defect in Igfbp4 expres-
sion was observed. Additionally, similar differences were
observed in the hindlimbs of Hoxa13/ (not shown).
The expression of Fstl was also analyzed. At late E12.5
in Hoxa13+/+ embryos (stage 9), Fstl is expressed in ID2–4
with the level in ID2 and ID3 greater than in ID4 (Fig. 6A).
The expression of Fstl at early E13.5 (stage 10) is decreased
in ID2 and ID3 and increased in ID4 (Fig. 6B). The
expression of Fstl in Hoxa13/ limb buds (Figs. 6C,D) isattenuated compared to that of the wild type littermates. A
consistent decrease in Fstl expression was observed in
replicate experiments in the Hoxa13/ embryos. In our
experience, the degree of loss is variable, however ID4
expression was always reduced. Together these data
demonstrate a genetic requirement for Hoxa13 for the
proper expression of Igfbp4 and Fstl in the interdigital
mesenchyme of developing limb buds.
Paralog and non-paralog target gene regulatory
capabilities
To test whether other HOX group 13 proteins regulate
the expression of candidate HOXA13 downstream genes,
we performed a transient transfection assay with HOXA13
and HOXD13 in the control EGFP-only cells. To simplify
the analysis, we looked at Blnk. We repeatedly demonstrated
by SQ RT-PCR that the expression of Blnk was upregulated
upon the transfection of either paralog (Fig. 7A). This
T.M. Williams et al. / Developmental Biology 279 (2005) 462–480474encouraged us to further explore the effect of paralogous as
well as nonparalogous HOX protein expression on a larger
set of candidate targets in stable cell lines, created as for
HOXA13, where we could harvest cell populations with
more homogeneous expression. Western blot analysis
demonstrated comparable expression of HOXA9 to that of
HOXA13, but much lower (at least 10-fold) levels of
HOXD13 were observed (data not shown). Expression was
tested by SQ RT-PCR for genes upregulated in the
HOXA13-expressing cells in comparison to the EGFP-only
cells. Increased expression was observed for Enpp2, Fabp4
and Fhl1 in HOXD13-, but not HOXA9-, expressing cells
(Fig. 7B). Blnk and Ifit1 showed no increase in either the
HOXD13- or HOXA9-expressing cells. Given that Blnk had
increased expression after transient HOXD13 expression, it
is likely that the lack of a response may be due to low
HOXD13 levels in this population of HOXD13 stable-
expressing cells. Since the SQ RT-PCR assay is not as useful
for detecting changes in expression of genes that are initially
highly expressed in the EGFP-only cells, we did not test the
expression of Fstl and Igfbp4. Ngef and Casp8ap2 had
lower expression levels in the HOXA13/EGFP-expressing
cells (Ngef, Fig. 2; Casp8ap2 decreased 1.3-fold, not
shown). HOXD13- and HOXA9-expressing cells also had
reduced expression of Ngef and Casp8ap2 (Fig. 7B) by a
magnitude consistent with that observed by microarray for
the HOXA13/EGFP-expressing cells (Table 3). Thus, these
results demonstrate that group 13 HOX proteins were
capable of upregulating a subset of the genes that HOXA9
could not, implying a paralog-specific regulatory effect.
However, the repression of Ngef and Casp8ap2 was a
shared property.
Downstream target gene regulation by HOXD13 monomeric
DNA-binding mutant
Previous studies have demonstrated the importance of
homeodomain (HD) residues 47, 50, and 51, that make
direct contact with the DNA (Gehring et al., 1994b). The
conversion of all of these residues (I, Q, N) to alanine
creates a protein unable to effectively bind a group 13 HD
binding site as a monomer in vitro (Caronia et al., 2003). To
test whether monomeric DNA-binding capability is a
requirement for target gene regulation, we created cells
stably expressing HOXD13IQN N AAA (as done for Hoxa13,
Hoxd13 and Hoxa9). Western blot analysis demonstrated
robust protein expression perhaps greater than for both the
HOXA9- and HOXD13-expressing cells (data not shown).
RNA prepared from these cells was analyzed by SQ RT-
PCR. Surprisingly, HOXD13IQN N AAA was able to
upregulate the expression of Enpp2, Fabp4 and Fhl1,
comparable to that of wild type HOXD13 (Fig. 7B). Also,
Blnk and Ifit1 were upregulated in cells expressing
HOXD13IQN N AAA, but not in those expressing wild type
HOXD13 or HOXA9. We ruled out the possibility that the
observed expression changes were secondary to HOX-D13IQN N AAA upregulating the endogenous expression of
HOXD13, since sequenced Hoxd13 RT-PCR products,
using gene specific primers, showed only the mutant
transcript is expressed (data not shown). For genes tran-
scriptionally repressed in the HOXA13-expressing cells,
Ngef and Casp8ap2, HOXD13IQN N AAA was unable to
repress their expression. However, HOXD13 and HOXA9
repressed these two genes. To test the reproducibility of
these results, we verified the differences, by SQ RT-PCR, in
an independent preparation of RNA from these same cell
lines.Discussion
In vitro system for identification of HOX-induced
downstream gene expression changes
The expression and activity of the evolutionarily
conserved transcription factor, HOXA13, is required for
the proper development of the limb autopod, umbilical
artery, caudal digestive and reproductive tracts (Fromental-
Ramain et al., 1996a; Goodman et al., 2000; Innis et al.,
2002; Mortlock and Innis, 1997; Mortlock et al., 1996;
Stadler et al., 2001; Warot et al., 1997). A disadvantage to
using individual Hox mutants to identify candidate down-
stream target genes is their well documented ability to
function redundantly (Greer et al., 2000; Rijli and Cham-
bon, 1997; Zakany and Duboule, 1999). Single Hox gene
mutants phenotypically often look mildly affected or
unremarkable compared to wild type mice. Double mutants
on the other hand, may lack entire structures, therefore
making target gene identification difficult.
To circumvent the problem of functional redundancy, we
expressed HOXA13 in mouse embryonic fibroblast cells
that do not express paralog group 13 proteins and assessed
gene expression changes with high-density gene arrays. A
cultured cell line cannot precisely recapitulate the complex
dynamics that occur in the developing limb bud. However,
the cell line offered the advantage, as recognized by other
authors who have used this approach, that the effect of
single genes could be explored in relatively homogeneous
populations, thereby minimizing the loss of candidate target
genes due to heterogeneous tissue effects (Dorsam et al.,
2004; Valerius et al., 2002). Combined expression with the
HOX cofactor MEIS would be a very interesting experi-
ment to pursue for potential targets regulated through
cooperative interactions, and such experiments could be
pursued in the future. However, it is important to point out
that in the distal limb bud, at least, a combined expression
of Hox group 13 genes and Meis genes does not occur, so
perhaps such coexpressed targets might be relevant to
another cellular context such as the reproductive tract
(Williams et al., 2005).
There were few significant, reproducible expression
changes in transinfected cells shortly after infection. This
Table 5
HOXA13-regulated genes also reported in other studies
Candidate
target
HOXA13
regulation
Previous
result(s)
Reference
M32486 Upregulated Upregulated Zhao Y. and Potter S. (2001)
Anxa8 Upregulated Upregulated Zhao Y. and Potter S. (2001)
Col5a1* Upregulated Upregulated Zhao Y. and Potter S. (2001)
Casp8ap2
(FLASH)
Downregulated Upregulated
by HOXB4
Morgan R. et al. (2004)
Ncam* Upregulated Upregulated
by HOXB9,
B9, and C6
Jones F.S. et al. (1992, 1993)
Integrin a8 No change Upregulated
by HOXA11
Valerius M.T. et al. (2002)
* Meets lower significance criteria: P value b0.05 and a fold change
of N1.5.
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expression, which by Western analysis was lower than
expected, and certainly lower than in the producer cells. It
might be expected based on genetic data that elevated HOX
protein dosage may cause more significant changes in
downstream gene expression (Zakany et al., 1997). How-
ever, we would characterize the expression levels in the
HOXA13 stable-expressing cells as near physiologic.
Importantly, we expressed only a single HOX protein in
these cells. Thus, the contribution of the additional
expression of Hoxd13, Hoxd12, and Hoxd11, as observed
in the autopod, would likely be increased above the total
Hox dose achieved in our cells.
73 probe sets representing 68 separate genes were
identified with reproducible expression differences in cells
stably-expressing HOXA13 and these differences were
verified for several candidates by SQ RT-PCR. For the
genes upregulated in the stable HOXA13-expressing cells,
expression changes ranged between +30.75-fold to our cut-
off of +1.75, and large fold changes were more often
observed for genes being expressed at initially low levels in
the control cells. Of the genes downregulated in the
HOXA13/EGFP-expressing cells, the fold changes were
between 5.88 for Ngef and 1.75 for Mox2. The
reproducible changes observed among paralogs, and for
some genes with the nonparalog HOXA9, indicate that these
cell lines may be useful in the dissection of downstream
gene regulatory mechanisms and cis-acting sequences of
additional HOX proteins.
Downstream HOX regulated genes
We demonstrated that, for genes upregulated in the
HOXA13/EGFP-expressing cells, 11 Gene Ontology (GO)
annotations are overrepresented at a significance level of P b
0.001. Among the GO terms are cellular components
including the bextracellular matrixQ, bcollagenQ and
bbasement membraneQ. Also represented are terms for
molecular functions including bextracellular matrix struc-
tural constituentQ and bextracellular matrix constituent
conferring tensile strengthQ. While not meeting the statistical
requirement used in Table 4, another GO term of interest is
bextracellularQ (P value b 0.005); 48 of the 181 genes in this
comparison have this annotation. Together, the data
demonstrates that extracellular protein regulation is a major
role of HOXA13; the modulation of these extracellular
properties is likely to be the primary route by which HOX
proteins control cell shape, motility, growth and adhesion.
Among the candidate genes we identified, a few have
been found in previous studies to be regulated by HOX
proteins and are consistent with a major role for HOX
proteins in the regulation of extracellular physiology
(Table 5). We identified Anxa8 and M32486 as being
upregulated by HOXA13. In studies in which the Hoxa13
homeobox was substituted for that of Hoxa11, which drives
the expression of a HOXA11 protein with a group 13homeodomain in the uterus, these two genes were among a
set of upregulated genes (Zhao and Potter, 2001). Cell
adhesion molecules and ephrin-receptors have emerged as
HOX-regulated targets (Stadler et al., 2001; Valerius et al.,
2002). HOX proteins of paralog group 1 have been shown
to regulate the expression of EphA2 in the developing
hindbrain (Chen and Ruley, 1998; Studer et al., 1998) and
HOXA9 regulates the expression of EphB4 in endothelial
cells (Bruhl et al., 2004). The loss of Hoxa13 expression is
associated with the downregulation of EphA4 and EphA7 in
mutant limb buds and in the umbilical artery (Stadler et al.,
2001). Additionally, retroviral misexpression of Hoxd13 in
chicken limb buds was associated with the upregulation of
EphA7 in the autopod, and appeared to require DNA-
binding (Caronia et al., 2003). EphrinB1–EphB interactions
are required for normal skeletal development, and genetic
disruption of this signaling pathway results in polydactyly
(Compagni et al., 2003). Here, EphB3 was upregulated in
the HOXA13-expressing cells 1.85-fold, however no
change was observed in EphA4 or EphA7. This may be
explained by the cellular context used or level of HOXA13
expression. While not meeting our criteria, several genes
showed altered expression whose involvement in the
extracellular matrix is compelling, including Ncam and
Col5a1, corroborating previous studies demonstrating these
as candidate HOX-regulated targets (Jones et al., 1993;
Zhao and Potter, 2001).
In the notochord, Hoxb4 has been shown to upregulate
the expression of the pro-apoptotic molecule Casp8ap2/
FLASH (Morgan et al., 2004); in our study, HOXA13
downregulated the transcription of Casp8ap2, and this
repression required DNA binding (see below). Thus,
different paralog groups may regulate the expression of
the same genes, but with potentially different outcomes
depending on cellular context and/or the specific HOX
cofactor(s) involved. The identification of the pro-apoptotic
gene reaper as a Hox target, in Drosophila, suggests that the
regulation of cell death is a conserved function of HOX
proteins (Lohmann et al., 2002).
Besides the limb bud and caudal female reproductive
tract, HOXA13 is expressed in the prostate, umbilical artery,
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al., 1996; Podlasek et al., 1999; Stadler et al., 2001; Warot et
al., 1997; Yamamoto et al., 1998). Thus, the potential role of
some genes identified here as downstream targets may only
be confirmed by exploring the relevant tissues. Fhl1, the
gene with the greatest activation in our experiments, is
known to be expressed during early stages of skeletal
muscle differentiation (Chu et al., 2000; McGrath et al.,
2003). Thus, perhaps this gene is activated by HOXA13 or
other posterior HOXA proteins during myoblast migration
into the limb (Yamamoto et al., 1998). Similarly, work with
M32486 in the female reproductive tract may be instructive
in understanding why HOXA13 so strongly activates its
expression in our experimental system and in vivo in
Hoxa11A13HD mice (Zhao and Potter, 2001). Finally, Enpp2/
autotaxin encodes a bifunctional enzyme with lysophos-
pholipase and phosphodiesterase nucleotide pyrophospha-
tase activities that is known to strongly regulate tumor and
normal cell motility (Hama et al., 2004). Genes involved in
the modulation of cell motility have been postulated as Hox
realizators (Garcia-Bellido, 1975), thus Enpp2 is a new
candidate target in this category. It is particularly attractive
given its downstream position in BMP pathways and
perhaps should be examined at later stages of limb
morphogenesis or bone maturation in Hoxa13 mutants. In
summary, future studies are needed to define the in vivo
contexts wherein these and other candidate downstream
targets are regulated by HOXA13 and perhaps other group
13 paralogs.
In vivo regulation of target gene expression
For a selected subset of the candidate downstream genes,
the expression pattern was found to be very similar to that of
Hoxa13, in localizing to the interdigital mesenchyme of the
developing autopods. The gene encoding the secreted IGF-
signaling antagonist, Igfbp4 , was shown to require
HOXA13 for proper in vivo expression. An absolute loss
of expression was not observed in autopodal regions where
Hoxd13 or other posterior Hoxd genes are coexpressed,
suggesting that Igfbp4 may be a shared target. At early
stages, Hoxd13 is not expressed in the anterior autopod in
the position of developing digit 1 and the first interdigital
mesenchyme (ID1; Fig. 4D) unlike that of Hoxa13 whose
expression extends to the anterior-most domain of the
autopod (Fig. 4C). The loss in ID1 and the persistent, albeit
reduced, expression of Igfbp4 in ID2–4 of the Hoxa13
mutant limb buds (compare Figs. 5C,F) may reflect
redundant regulation by HOXD13, or other autopod-
expressed Hox genes. IGFBP-4 is one of six secreted
IGFBPs which is unique from the others in that it functions
consistently to inhibit IGF actions (Wetterau et al., 1999).
IGFBP4 has been shown to potently block bone cell growth
and IGF-mediated cell proliferation (Mohan et al., 1989)
and differentiation in various cell types (Zhou et al., 2003).
Based on this information, it is plausible that paralog group13 HOX proteins regulate the expression of IGFBP4 to help
direct the sites and/or shape of bone formation within the
developing autopod.
Like Igfbp4 , Fstl is expressed in the interdigital
mesenchyme of the developing limb buds and encodes a
secreted protein whose expression is misregulated in
Hoxa13 mutant limb buds (Fig. 6). FSTL is one of many
BMP-signaling antagonists, such as follistatin, chordin, and
noggin, that function through interaction with signaling
ligands preventing interaction with their cellular receptors
(Canalis et al., 2003). BMP-signaling induces mesenchymal
cells to differentiate into cells of the osteoblastic lineage
(Gitelman et al., 1995; Yamaguchi et al., 1996). The
overexpression of BMP-2 and BMP-4 in the developing
limbs results in an increase in cartilage cell number and in
matrix cartilage (Duprez et al., 1996). During limb develop-
ment, BMP-signaling has been demonstrated to promote
interdigital apoptosis and inhibition results in syndactyly
(Yokouchi et al., 1996; Zou and Niswander, 1996). There-
fore, the regulation of Fstl by HOXA13 may influence
mesenchymal cell differentiation and the onset of cell death.
Whether or not this plays a role in the interdigital
syndactyly observed in ID1 in Hoxa13/ mutants is
unknown.
How many downstream genes do HOX proteins regulate?
The ability of HOX proteins to regulate morphogenesis
has long been hypothesized to operate through the
regulation of many genes, known as realizators, whose
encoded proteins directly function in the processes such as
cell shape, division, survival, apoptosis, motility, adhesion,
and differentiation (Garcia-Bellido, 1975). This hypothesis
has largely been proven correct, and recent work has
demonstrated that HOX proteins can also regulate the
expression of other transcription factors as well as signaling
molecules (Weatherbee et al., 1998). An important question
in understanding HOX function is how many genes are
subject to HOX regulation? Several studies, in Drosophila,
have shown that HOX proteins are bound to many sites
within the genome (Biggin and McGinnis, 1997; Walter et
al., 1994), and that greater than 25% of expressed genes are
directly or indirectly regulated by HOX proteins (Liang and
Biggin, 1998). In contrast, in our study, we estimate that
fewer than 1% of the genes (68/~9000) on the chip are
regulated by HOXA13 expression. The low percentage of
targets observed here is consistent with the findings of other
studies that explored a large number of genes as potential
HOX targets (Hedlund et al., 2004; Valerius et al., 2002;
Zhao and Potter, 2001). However, perhaps the cellular
context, availability of chromatin, or cofactor expression
limited the number of observed expression changes in our
experiments. It is also possible that higher levels of group
13 protein expression could cause greater expression
changes and may mimic the expression of multiple paralogs
in the same cell.
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A shared feature of all HOX proteins is the presence of
a 60 amino acid homeodomain, which is well known for its
ability to bind DNA. The regulation of transcriptional
targets by HOX proteins has been shown to occur through
DNA target-site recognition and binding by this protein
domain with (Mann and Affolter, 1998; Mann and Morata,
2000) or without cofactors (Galant et al., 2002). There is a
significant body of literature, primarily from Drosophila
studies, demonstrating in vivo function by these means
(Gebelein et al., 2002; Kobayashi et al., 2003). To our
surprise, HOXD13IQN N AAA, a protein incapable of
binding to DNA as a monomer, is fully capable of
upregulating the expression of 5 tested genes (Blnk, Enpp2,
Fabp4 , Fhl1, and Ifit1). Conversely, HOXD13 and
HOXA9 were shown to downregulate Casp8ap2 and Ngef,
however HOXD13IQN N AAA could not. Thus, with this
limited number of downstream genes, paralog group 13
HOX proteins can act as transcriptional activators even
though incapable of binding DNA as a monomer.
Repression, in our data, requires the ability to bind DNA
and can be accomplished on common genes by a non-
paralogous (HOXA9) protein. Similar findings were
observed for HOXC8 repression on Osteopontin and
Osteoprotegrin promoter activity (Shi et al., 1999; Wan
et al., 2001). Mutation of the HOXC8 binding-site was
shown to abolish HOX-mediated repression.
Homeodomain proteins have been shown to retain
function in the absence of DNA-binding. Mutants of the
Drosophila homeodomain protein Ftz, with either altered
DNA-binding specificity or inability to bind DNA, retain
substantial wild type function, suggesting that some Ftz
targets are regulated through protein–protein interactions
(Ananthan et al., 1993; Copeland et al., 1996; Fitzpatrick et
al., 1992; Hyduk and Percival-Smith, 1996; Schier and
Gehring, 1993). Similar findings were demonstrated for the
yeast a2 homeodomain repressor protein, where the direct
regulation of targets by mutant monomeric a2 as well as a2/
MCM1 heterodimer was impaired. However, identical a2
mutants still retained the ability to cooperatively bind DNA
with a1 to effectively repress haploid specific genes in vivo
(Vershon et al., 1995). DNA binding-independent functions
of HOX proteins have also been observed in vertebrates.
The antagonistic effect of HOXD8 on HOXD9 autoregula-
tion, through the HCR element, is DNA-binding independ-
ent and likely mediated through protein–protein interactions
(Zappavigna et al., 1994). A DNA-binding impaired
HOXD12 can effectively convert the GLI3 repressor into
a transcriptional activator (Chen et al., 2004). Additionally,
HOXA13 with the homeodomain deleted still appears
capable of acting as a strong transcriptional activator of
the Bmp-4 promoter (Suzuki et al., 2003). Furthermore, the
homeodomains of HOX proteins from multiple paralog
groups, including group 13, have been shown to interact
with CBP (Shen et al., 2001). Interestingly, interaction withCBP not only inhibited DNA-binding of HOX proteins, but
also inhibited the histone acetyltransferase activity of CBP.
The lysine at position 55 of the third helix of the HOXB7
homeodomain was necessary for this in vivo function. Thus,
it would be interesting to test whether lysine 55 in the group
13 HOX proteins is necessary for the transcriptional effects
we measured.
In summary, while DNA-binding independent functions
have been an observed mechanism of HOX function, the
frequent observation in our studies of this activity in
downstream gene activation was unexpected. Thus, we
wish to amplify the proposal of Shen et al., 2001, that HOX
protein functions are not limited to DNA bound activities,
by suggesting that the prevalence of HOX proteins
regulating gene expression as the non DNA-binding partner
or in solution off of DNA with a cofactor could be much
greater than generally assumed.Acknowledgments
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